etoposide has been researched along with Chemotherapy-Induced Febrile Neutropenia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, D; Kong, X; Liu, S; Yu, C; Zhu, Y | 1 |
| Lomma, C; Ransom, D | 1 |
| Han, D; Li, S; Ren, X; Shang, W; Sun, L; Wang, G; Xu, L | 1 |
| Bergin, K; Coutsouvelis, J; Fedele, P; Grigoriadis, G; Kalff, A; Low, MSY; Spencer, A; Walker, P; Yuen, HLA | 1 |
| Caballero, MD; Canales, M; de la Cruz, F; Domingo-Domenech, E; Garcia-Sanz, R; Gonzalez, AP; Gutierrez, A; Jimenez-Cabrera, S; Lopez, J; Martinez, C; Moreno, M; Pinana, JL; Rodriguez, A; Rodriguez, G; Rodriguez-Salazar, MJ; Sanchez-Gonzalez, B; Sureda, A | 1 |
| Argiris, A; Gooding, WE; McLaughlin, B; Schmitz, JC; Siegfried, JM; Socinski, MA; Tarhini, AA; Zahoor, H | 1 |
| Jang, JH; Jung, CW; Kim, K; Kim, SJ; Kim, WS; Lee, SJ; Park, S | 1 |
| Aggarwal, C; Belani, CP; Dahlberg, SE; Dowell, J; Gerber, DE; Hann, CL; Khan, SA; Moss, RA; Owonikoko, TK; Ramalingam, SS | 1 |
| Harada, M; Inoue, A; Ishida, T; Kinoshita, I; Maemondo, M; Mori, Y; Morikawa, N; Nakagawa, T; Nukiwa, T; Oizumi, S; Saito, R; Sugawara, S; Suzuki, T; Taima, K; Watanabe, H | 1 |
| Biswas, A; Julka, PK | 1 |
1 review(s) available for etoposide and Chemotherapy-Induced Febrile Neutropenia
| Article | Year |
|---|---|
Comparison of irinotecan/platinum versus etoposide/platinum chemotherapy for extensive-stage small cell lung cancer: A meta-analysis.
Topics: Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Diarrhea; Etoposide; Fatigue; Humans; Irinotecan; Leukopenia; Lung Neoplasms; Nausea; Neoplasm Staging; Neutropenia; Odds Ratio; Proportional Hazards Models; Small Cell Lung Carcinoma; Thrombocytopenia; Vomiting | 2017 |
4 trial(s) available for etoposide and Chemotherapy-Induced Febrile Neutropenia
| Article | Year |
|---|---|
Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group).
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Prednisone; Progression-Free Survival; Salvage Therapy; Transplantation, Autologous; Young Adult | 2019 |
Phase I trial of carboplatin and etoposide in combination with panobinostat in patients with lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Early Termination of Clinical Trials; Etoposide; Humans; Hydroxamic Acids; Indoles; Lung Neoplasms; Middle Aged; Panobinostat | 2013 |
A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Etoposide; Fatigue; Female; Heart Failure; Humans; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma; Thrombocytopenia | 2015 |
Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Irinotecan; Japan; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Retreatment; Small Cell Lung Carcinoma; Survival Rate | 2015 |
5 other study(ies) available for etoposide and Chemotherapy-Induced Febrile Neutropenia
| Article | Year |
|---|---|
A Risk-Prediction Nomogram for Neutropenia or Febrile Neutropenia after Etoposide-Based Chemotherapy in Cancer Patients: A Retrospective Cohort Study.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Etoposide; Female; Humans; Logistic Models; Male; Middle Aged; Neoplasms; Nomograms; Predictive Value of Tests; Retrospective Studies; Risk Assessment; ROC Curve | 2022 |
Chemotherapy dosing and toxicity in a patient with muscular dystrophy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Muscular Dystrophies, Limb-Girdle; Myelopoiesis; Palliative Care | 2018 |
DCEP as a bridge to ongoing therapies for advanced relapsed and/or refractory multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Cyclophosphamide; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Progression-Free Survival | 2018 |
DCEP for relapsed or refractory multiple myeloma after therapy with novel agents.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Drug Evaluation; Drug Resistance, Neoplasm; Etoposide; Fatigue; Female; Gastrointestinal Diseases; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mucositis; Multiple Myeloma; Peripheral Nervous System Diseases; Recurrence; Retrospective Studies; Transplantation, Autologous; Treatment Outcome | 2014 |
Bleomycin induced flagellate erythema in a patient with thalamic mixed germ cell tumour: Report of a rare adverse effect.
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Bleomycin; Cetirizine; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Combined Modality Therapy; Craniospinal Irradiation; Erythema; Etoposide; Fatal Outcome; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Supratentorial Neoplasms; Thalamus | 2016 |